You searched for "implant"
Cataract surgery in small adult eyes
This is a retrospective audit of a five year study period, between the periods of January 2006 to December 2010, where a surgical log book search was performed. The inclusion criteria of this study were intraocular lenses (IOL) power greater...
Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders
3 February 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Aflibercept, Anti-VEGF, Dexamethasone implant, Diabetic macular oedema, Persistent, Ranibizumab, Resistant
This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...
Sight Sciences Celebrates 150th Certified UK OMNI Surgeon
Sight Sciences is proud to announce that 150 ophthalmic surgeons in the United Kingdom are now certified to use the OMNI® Surgical System. This milestone was marked by the recent certification of Ms. Diana Urbaneja, Consultant Ophthalmic Surgeon at University...Doctor prints cornea on demand!
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Doctor prints cornea on demand! Dr Hideo Kodama from the Nagoya Municipal Industrial Research Institute first...Technology in ophthalmology – a promising future and what we need to know about the regulations
1 October 2017
| Priya Nidamanuri, Magdalena Popiela
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Orbit, EYE - Vitreo-Retinal, EYE - General
Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...
Unconscious bias (part 2)
5 February 2020
| Clare Inkster
|
EYE - General
Does unconscious bias exist, and does training help to reduce discriminatory behaviour? Clare Inkster questions her role as a trainer. I read Gwyn Williams’ Learning Curve article on this topic a few months ago with interest, and as someone who...
Retinoblastoma management update (part 2): treatment, screening and surveillance, long-term follow-up and new developments
1 February 2017
| Manoj V Parulekar
|
EYE - Oncology
Retinoblastoma treatment requires significant multidisciplinary input, but early detection through raising awareness remains key to improving outcomes. In the second article of a two-part series, Manoj Parulekar discusses retinoblastoma management, screening and research. This article has been published in two...
Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...CHEC expands transformative MIGS service
23 September 2024
|
industry, private sector, glaucoma, MIGS, surgery, healthcare, Minimally invasive
CHEC, a community healthcare provider delivering specialist ophthalmology services on behalf of the NHS, has announced the expansion of its minimally invasive glaucoma surgery (MIGS) service. MIGS is an innovative approach combining glaucoma treatment with cataract surgery, utilising advanced techniques...
Moorfields International refractive symposium
24 April 2025
The Moorfields International refractive symposium covers contemporary vision correction surgery to surgeons in the UK and around the world. Taking place on Thursday 24 April at the Royal College of Physicians in London (08:30 - 17:45), the symposium aims to...
Ologen Collagen Matrix to treat ocular hypotony after filtration glaucoma surgery
1 April 2018
| Sofia Rokerya
|
EYE - Glaucoma
The authors report a retrospective, observational case series of a Japanese cohort. 12 consecutive implantations of ologen in nine eyes of nine subjects (five men, four women; mean age ±SD, 72.1±12.7 years) who underwent subconjunctival implantation of the device to...
